Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:BFINVESTHealthcare
Clear all filters
Park Medi World stock price climbs to a new peak after this update
positive
LiveMint - Markets 124d ago

Park Medi World stock price climbs to a new peak after this update

Park Medi World shares, which listed on the exchanges on December 17 last year, jumped as much as 3.5% to a new peak of ₹208.72 apiece. The IPO investors are meanwhile enjoying 30% returns on their investment as against the offer price of ₹162 apiece.

BFINVESTPARKHOSPSFinancial ServicesHealthcare
Cipla enters biologics joint venture with Kemwell, expands presence in Middle East
neutral
CNBC TV18 - Markets 131d ago

Cipla enters biologics joint venture with Kemwell, expands presence in Middle East

Biologics venture to see initial investment of up to ₹10 crore; Cipla (EU) forms Cipla Middle East Company in Saudi Arabia

BFINVESTCIPLAFinancial ServicesHealthcare
NHAI-backed Raajmarg Infra Investment Trust's IPO to open on Mar 11
positive
Business Standard - Markets 131d ago

NHAI-backed Raajmarg Infra Investment Trust's IPO to open on Mar 11

State-owned NHAI-sponsored Raajmarg Infra Investment Trust (RIIT) is gearing up to launch its Rs 6,000 crore Initial Public Offering (IPO). The InvIT's maiden public offering will open on March 11 and conclude on March 13, while the bidding for anchor investors will take place on March 10, according to a public announcement on Monday. The initiative marks an important step in broadening public participation in the National Highway infrastructure growth story. The public InvIT aims to unlock the monetisation potential of the National Highway assets while creating a high-quality, long-term investment instrument primarily targeting retail and domestic investors. As per the Red Herring Prospectus (RHP), Raajmarg Infra Investment Trust's IPO issue size aggregates up to Rs 6,000 crore. This was an increase from Rs 5,700 crore planned at the time of filing draft papers in January. Earlier, NHAI had incorporated Raajmarg Infra Investment Managers Pvt. Ltd. (RIIMPL) as the investment mana

BFINVESTHILINFRAIITLINFRAIVCLTGILTBEESRETAILSDREAMSTAKETHEINVESTTRUSTV2RETAILConsumer ServicesFinancial Services
Looking to take success from India to other emerging markets: Acerpure
positive
ET Markets - Industry 135d ago

Looking to take success from India to other emerging markets: Acerpure

Acerpure, a consumer electronics brand, is set to expand its presence in emerging markets like the Philippines, Vietnam, Thailand, and Indonesia. The company aims to double its sales and investment in India this year. Acerpure is also focusing on launching products tailored for the Indian market, emphasizing 'made in India' initiatives.

BFINVESTCONSUMERGANESHCPGODREJCPJUBLCPLLGEINDIALIBASTAKETATACONSUMChemicalsConsumer Durables
Assam CM inaugurates Star Cement’s Cachar unit, Boosting Industrial Footprint in Barak Valley
positive
ET Markets - Industry 141d ago

Assam CM inaugurates Star Cement’s Cachar unit, Boosting Industrial Footprint in Barak Valley

Assam Chief Minister Himanta Biswa Sarma opened Star Cement Ltd.'s new plant in Cachar. This Rs 400 crore facility will boost cement availability in southern Assam and nearby states. It is expected to create over 1,000 jobs. The investment highlights growing confidence in Assam's industrial growth. The unit will support regional development and meet rising demand.

BFINVESTBVCLIITLJKCEMENTSTARSTARCEMENTConstruction MaterialsFinancial Services
Zydus Lifesciences, Sunshine Healthcare to invest over $20 million in Sri Lanka manufacturing venture
positive
Moneycontrol NaNd ago

Zydus Lifesciences, Sunshine Healthcare to invest over $20 million in Sri Lanka manufacturing venture

The new entity, Zydus Sunshine Lifesciences Pvt. Ltd., will establish a manufacturing plant on nearly four acres of land at the Board of Investment’s Horana zone.

3PLANDBFINVESTHCGHCG-REHEALTHCAREZYDUSLIFEFinancial ServicesHealthcare
Trade Spotlight: How should you trade Authum Investment, Gland Pharma, Thermax, Aurobindo Pharma, Bajaj Auto, and others on May 22?
positive
Moneycontrol NaNd ago

Trade Spotlight: How should you trade Authum Investment, Gland Pharma, Thermax, Aurobindo Pharma, Bajaj Auto, and others on May 22?

The market needs a decisive move above the upper end of the 23,300–23,800 range for a fresh leg of rally. Until then, consolidation may continue. Below are some short-term trading ideas to consider.

AIILAUROPHARMABAJAJ-AUTOBAJAJHLDNGBFINVESTGLANDTHERMAXAutomobile and Auto ComponentsCapital Goods
Trade Spotlight: How should you trade Medanta, Tata Motors, Cholamandalam Investment, Radico Khaitan, Kotak Bank, Inox Green, and others on June 29?
neutral
Moneycontrol NaNd ago

Trade Spotlight: How should you trade Medanta, Tata Motors, Cholamandalam Investment, Radico Khaitan, Kotak Bank, Inox Green, and others on June 29?

The consolidation may continue as long as the market trades below Friday's high. Below are some short-term trading ideas to consider.

BANKINDIABANKNIFTY1BFINVESTCHOLAFININOXGREENINOXINDIAKHAITANLTDKOTAKBANKLTGILTBEESMEDANTANPBETPSUBANKRADICOTATAINVESTTATATECHTMCVTMPVAutomobile and Auto ComponentsCapital Goods
Stocks to Watch Today: Emcure, Aurobindo Pharma, HFCL, RBL Bank, Coal India, Tata Steel, ITC Hotels, Power Grid, Godfrey Phillips in focus on 18 May
positive
Moneycontrol NaNd ago

Stocks to Watch Today: Emcure, Aurobindo Pharma, HFCL, RBL Bank, Coal India, Tata Steel, ITC Hotels, Power Grid, Godfrey Phillips in focus on 18 May

RBL Bank has announced the completion of the regulatory and governmental approval process for the proposed strategic investment by Emirates NBD Bank.

ABHAPOWERAUROPHARMABANKINDIABFINVESTCOALINDIAEMCUREFOCUSGODFRYPHLPGVPILHFCLITCITCHOTELSMSPLNPBETPOWERGRIDRBLBANKSALSTEELTATAINVESTTATAPOWERTATASTEELTATATECHCapital GoodsConsumer Durables
With Wockhardt securing USFDA nod for Zaynich, focus shifts from lab to market
positive
Moneycontrol NaNd ago

With Wockhardt securing USFDA nod for Zaynich, focus shifts from lab to market

After decades of sustained investment in antibiotic research, Wockhardt has secured approvals for its breakthrough drug Zaynich. The challenge now is converting scientific success into commercial returns.

BFINVESTFOCUSWOCKPHARMAConsumer DurablesFinancial Services
Vodafone Idea share surges 6% as Kumar Mangalam Birla backs turnaround, promoter funding plan
positive
Moneycontrol NaNd ago

Vodafone Idea share surges 6% as Kumar Mangalam Birla backs turnaround, promoter funding plan

The stock rose as much as 5.6% to Rs 14.96 in afternoon trade after shareholders approved a Rs 4,730-crore investment from the Aditya Birla Group through a preferential allotment of warrants at an extraordinary general meeting

ABCAPITALABFRLABGSECABLBLABRELABSL10BANKABSLAMCABSLBANETFABSLLIQUIDABSLNN50ETABSLPSEARSSBLBFINVESTBIRLACORPNBIRLAMONEYBSLGOLDETFBSLNIFTYBSLSENETFGGSEC10ABSLHEALTHYIDEAMANGALAMMGELMOMENTUMNIFTYQLITYSILVERTECHConstruction MaterialsConsumer Services
Prev
566